Form4insider filings, from the source

SEC Form 4 · accession 0001104659-15-012641

NPS PHARMACEUTICALS INC · NPSP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Eric Pauwels
Officer — President, NPS Pharma Int'l
Period of report
Feb 7, 2015
Accepted (ET)
Feb 20, 2015 · 4:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890465

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Feb 7, 2015J4,867—A24,766D
Common StockFeb 7, 2015F1,662$45.85D23,104D
Common StockF4Feb 12, 2015M2,787—A25,891D
Common StockFeb 12, 2015F957$45.85D24,934D
Common StockF4Feb 13, 2015M8,100—A33,034D
Common StockFeb 13, 2015F3,005$45.88D30,029D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF5,F6—Feb 12, 2015M2,787D——Common Stock2,7875,575D
Restricted Stock UnitsF5,F7—Feb 12, 2015A4,362A——Common Stock4,3624,362D
Restricted Stock UnitsF5,F8—Feb 13, 2015M8,100D——Common Stock8,1008,101D

Explanation of responses